Clinical Trial Update: A Follow-on Study for Second-Eye Treatment for Participants Previously Treated With Gene Therapy for X-Linked Retinitis Pigmentosa (XLRP) [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 follow-on study evaluating a second-eye treatment in participants with X-linked retinitis pigmentosa who previous…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• X-linked Retinitis Pigmentosa

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: X-Linked Retinitis Pigmentosa | Phase 2 | Status: ACTIVE_NOT_RECRUITING